BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in Norway.
Conclusions: The spectrum of BRCA1 and BRCA2 mutations in the carrier population at Norway's largest cancer genetics clinic is diverse, and with a weaker founder effect than previously described. As a consequence, retesting the families that previously have been tested with specific tests/founder mutation tests should be a prioritised strategy to find more mutation positive families and possibly prevent cancer in healthy relatives.
PMID: 29339979 [PubMed]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Heramb C, Wangensteen T, Grindedal EM, Ariansen SL, Lothe S, Heimdal KR, Mæhle L Tags: Hered Cancer Clin Pract Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | Genetics | Iceland Health | Norway Health | Poland Health | Study